ARCHIVES

NCI Planning Phase III Study Of Avastin For Metastatic Colorectal Cancer

This article is from The Cancer Letter archive.

Vol. 26 No. 6 | June 27, 2003

Download PDF Visit The Full Archive

Related Articles

Patenting the Gene: Cancer Advocates and Industry Diverge on Myriad Ruling

June 14, 2013

FDA Approves Rituxan For NHL With CHOP Therapy

February 24, 2006

Cancer Screenings: American Over 50 Urged to Get Colon Caner Tests

March 5, 1999

Funding opportunities listed.

April 30, 2004

NCI Sends Letter To Grantees To Explain Tighter Funding.

March 16, 2001

Avastin doubles progression-free survival in metastatic disease.

May 27, 2005